<unk>  is primarily used for the treatment of dyslipidemia and the prevention of cardiovascular disease. It is recommended to be used only after other measures, such as diet, exercise, and weight reduction, have not improved cholesterol levels. The evidence for the use of<unk>  is generally weaker than for other statins. The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT), failed to demonstrate a difference in all-cause mortality or nonfatal myocardial infarction/fatal coronary heart disease rates between patients receiving<unk>  40 mg daily (a common starting dose) and those receiving usual care.
Pravastatin
Fluvastatin
Atorvastatin
Lovastatin
Simvastatin
Clofibrate
Ezetimibe
Fenofibrate